- +30 Years of Experience
Register Your Medical Devices in Brazil and Unlock Market Access
Complete Market Access + Regulatory Compliance with ANVISA, All in One Package.
Schedule a Free Consultation
Brisa Advisors has been trusted by leading Companies
Imagine entering Brazil's booming medical devices market effortlessly, with every regulatory hurdle handled for you.
With Brisa, that’s not just possible; it’s guaranteed.
Navigating Brazil’s market might seem daunting — regulatory complexities, market access barriers.
These challenges are real, but so is the solution. Let’s address these hurdles head-on.
EXCLUSIVE OFFER: Register Your Medical Devices and Unlock Free Market Access!
Secure your regulatory compliance with Brisa and enjoy an exclusive benefit: receive 1 year of complimentary access to our marketplace.
This access not only connects you to a broad network of potential clients but also provides a platform to showcase your products in the thriving Brazilian medical market.
Brazil's Market: huge potential beyond complexity
Sure, stepping into Brazil’s market has its complexities — from intricate distributor networks and detailed tax systems to import regulations, bureaucratic procedures, and compliance with ANVISA, INMETRO, ANATEL, and GMP certification.
But here’s the exciting part: with Brisa Advisors, these complexities become manageable. Our extensive experience, spanning nearly three decades in regulatory, governmental, and commercial domains, equips us to smooth out these hurdles, paving the way for your product’s successful market entry.
Brazil is the largest medical device market in Latin America, pulsating with growth and opportunity. The demand for top-notch healthcare solutions is skyrocketing, creating a fertile ground for manufacturers ready to make a mark.
BRISA ADVISORS
Who we are
Brisa Advisors, a Regulatory Affairs consulting company, has acted for dozens of small, medium, and large international medical device manufacturing companies before ANVISA, such as Colgate Palmolive, Hoechst, Bayer, Sumitomo, and TELEFLEX group.
Acted in the areas of drugs, food, sanitizing products, cosmetics, and mainly medical devices. It stood out in the first merger case in which they acted to change the understanding of the legislation in force, motivating the change of the regulatory framework of ANVISA.
The change provided significant savings to its client in the payment of fees to ANVISA.